Article
Robert Frantz, MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic, discusses the rate of bloodstream infections in patients with pulmonary arterial hypertension treated with Veletri. Dr Franz also talks about the PROSPECT registry analysis.
Robert Frantz,
MD, FACC, Director, Pulmonary Hypertension Clinic, Mayo Clinic,
discusses the rate of bloodstream infections in patients with pulmonary arterial hypertension treated with Veletri. Dr Franz also talks about the PROSPECT registry analysis.
This video was taken on Sunday, October 21 at the CHEST 2012 conference in Atlanta, GA.